Cargando…
A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection
PURPOSE: Hepatitis B viral markers may be useful for predicting outcomes such as liver-related deaths or development of hepatocellular carcinoma. We determined the frequency of these markers in different clinical stages of chronic hepatitis B infection. METHODS: We compared baseline hepatitis B vira...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2896649/ https://www.ncbi.nlm.nih.gov/pubmed/20827410 http://dx.doi.org/10.1007/s12072-010-9179-1 |
_version_ | 1782183375323267072 |
---|---|
author | Tong, Myron John Hsu, Leeyen Hsien, Carlos Kao, Jia-Horng Durazo, Francisco Antonio Saab, Sammy Blatt, Lawrence Mitchell |
author_facet | Tong, Myron John Hsu, Leeyen Hsien, Carlos Kao, Jia-Horng Durazo, Francisco Antonio Saab, Sammy Blatt, Lawrence Mitchell |
author_sort | Tong, Myron John |
collection | PubMed |
description | PURPOSE: Hepatitis B viral markers may be useful for predicting outcomes such as liver-related deaths or development of hepatocellular carcinoma. We determined the frequency of these markers in different clinical stages of chronic hepatitis B infection. METHODS: We compared baseline hepatitis B viral markers in 317 patients who were enrolled in a prospective study and identified the frequency of these tests in immune-tolerant (IT) patients, in inactive carriers, and in patients with either hepatitis B e antigen (HBeAg)-positive or HBeAg-negative chronic hepatitis or cirrhosis. RESULTS: IT patients were youngest (median age 27 years) and HBeAg-negative patients with cirrhosis were oldest (median age 58 years) (p = 0.03 to <0.0001). The male to female ratio was similar both in IT patients and in inactive carriers, but there was a male preponderance both in patients with chronic hepatitis and in patients with cirrhosis (p < 0.0001). The A1896 precore mutants were most prevalent in inactive carriers (36.4%) and HBeAg-negative patients with chronic hepatitis (38.8%; p < 0.0001), and the T1762/A1764 basal core promoter mutants were most often detected in HBeAg-negative patients with cirrhosis (65.1%; p = 0.02). Genotype A was detected only in 5.3% of IT patients, and genotype B was least often detected in both HBeAg-Positive patients with chronic hepatitis and cirrhosis (p = 0.03). The hepatitis B viral DNA levels were lowest in inactive carriers (2.69 log(10) IU/mL) and highest in IT patients (6.80 log(10) IU/mL; p = 0.02 to <0.0001). At follow-up, HBeAg-positive and HBeAg-negative patients with cirrhosis accounted for 57 of 64 (89.1%) liver-related deaths (p < 0.0001). CONCLUSION: Differences in baseline hepatitis B viral markers were detected in patients in various clinical stages of hepatitis B virus infection. HBeAg-positive and HBeAg-negative patients with cirrhosis accounted for the majority of the liver-related fatalities. |
format | Text |
id | pubmed-2896649 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-28966492010-07-29 A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection Tong, Myron John Hsu, Leeyen Hsien, Carlos Kao, Jia-Horng Durazo, Francisco Antonio Saab, Sammy Blatt, Lawrence Mitchell Hepatol Int Original Article PURPOSE: Hepatitis B viral markers may be useful for predicting outcomes such as liver-related deaths or development of hepatocellular carcinoma. We determined the frequency of these markers in different clinical stages of chronic hepatitis B infection. METHODS: We compared baseline hepatitis B viral markers in 317 patients who were enrolled in a prospective study and identified the frequency of these tests in immune-tolerant (IT) patients, in inactive carriers, and in patients with either hepatitis B e antigen (HBeAg)-positive or HBeAg-negative chronic hepatitis or cirrhosis. RESULTS: IT patients were youngest (median age 27 years) and HBeAg-negative patients with cirrhosis were oldest (median age 58 years) (p = 0.03 to <0.0001). The male to female ratio was similar both in IT patients and in inactive carriers, but there was a male preponderance both in patients with chronic hepatitis and in patients with cirrhosis (p < 0.0001). The A1896 precore mutants were most prevalent in inactive carriers (36.4%) and HBeAg-negative patients with chronic hepatitis (38.8%; p < 0.0001), and the T1762/A1764 basal core promoter mutants were most often detected in HBeAg-negative patients with cirrhosis (65.1%; p = 0.02). Genotype A was detected only in 5.3% of IT patients, and genotype B was least often detected in both HBeAg-Positive patients with chronic hepatitis and cirrhosis (p = 0.03). The hepatitis B viral DNA levels were lowest in inactive carriers (2.69 log(10) IU/mL) and highest in IT patients (6.80 log(10) IU/mL; p = 0.02 to <0.0001). At follow-up, HBeAg-positive and HBeAg-negative patients with cirrhosis accounted for 57 of 64 (89.1%) liver-related deaths (p < 0.0001). CONCLUSION: Differences in baseline hepatitis B viral markers were detected in patients in various clinical stages of hepatitis B virus infection. HBeAg-positive and HBeAg-negative patients with cirrhosis accounted for the majority of the liver-related fatalities. Springer-Verlag 2010-04-07 /pmc/articles/PMC2896649/ /pubmed/20827410 http://dx.doi.org/10.1007/s12072-010-9179-1 Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Original Article Tong, Myron John Hsu, Leeyen Hsien, Carlos Kao, Jia-Horng Durazo, Francisco Antonio Saab, Sammy Blatt, Lawrence Mitchell A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection |
title | A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection |
title_full | A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection |
title_fullStr | A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection |
title_full_unstemmed | A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection |
title_short | A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection |
title_sort | comparison of hepatitis b viral markers of patients in different clinical stages of chronic infection |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2896649/ https://www.ncbi.nlm.nih.gov/pubmed/20827410 http://dx.doi.org/10.1007/s12072-010-9179-1 |
work_keys_str_mv | AT tongmyronjohn acomparisonofhepatitisbviralmarkersofpatientsindifferentclinicalstagesofchronicinfection AT hsuleeyen acomparisonofhepatitisbviralmarkersofpatientsindifferentclinicalstagesofchronicinfection AT hsiencarlos acomparisonofhepatitisbviralmarkersofpatientsindifferentclinicalstagesofchronicinfection AT kaojiahorng acomparisonofhepatitisbviralmarkersofpatientsindifferentclinicalstagesofchronicinfection AT durazofranciscoantonio acomparisonofhepatitisbviralmarkersofpatientsindifferentclinicalstagesofchronicinfection AT saabsammy acomparisonofhepatitisbviralmarkersofpatientsindifferentclinicalstagesofchronicinfection AT blattlawrencemitchell acomparisonofhepatitisbviralmarkersofpatientsindifferentclinicalstagesofchronicinfection AT tongmyronjohn comparisonofhepatitisbviralmarkersofpatientsindifferentclinicalstagesofchronicinfection AT hsuleeyen comparisonofhepatitisbviralmarkersofpatientsindifferentclinicalstagesofchronicinfection AT hsiencarlos comparisonofhepatitisbviralmarkersofpatientsindifferentclinicalstagesofchronicinfection AT kaojiahorng comparisonofhepatitisbviralmarkersofpatientsindifferentclinicalstagesofchronicinfection AT durazofranciscoantonio comparisonofhepatitisbviralmarkersofpatientsindifferentclinicalstagesofchronicinfection AT saabsammy comparisonofhepatitisbviralmarkersofpatientsindifferentclinicalstagesofchronicinfection AT blattlawrencemitchell comparisonofhepatitisbviralmarkersofpatientsindifferentclinicalstagesofchronicinfection |